申请人:Han Wei
公开号:US20090253766A1
公开(公告)日:2009-10-08
The present invention provides compounds of Formula (I):
or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein the variables A, L
1
, R
3
, and R
11
are as defined herein. The compounds of Formula (I) are useful as selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; for example thrombin, factor Xa, factor XIa, factor IXa, factor VIIa and/or plasma kallikrein. In particular, it relates to compounds that are selective factor XIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
本发明提供了式(I)的化合物:或其立体异构体、互变异构体、药学上可接受的盐、溶剂化物或前药,其中变量A、L1、R3和R11如本文所定义。式(I)的化合物可用作凝血级联和/或接触激活系统的丝氨酸蛋白酶酶的选择性抑制剂,例如凝血酶、Xa因子、XIa因子、IXa因子、VIIa因子和/或血浆卡利肌酶。特别地,涉及到选择性XIa因子抑制剂的化合物。本发明还涉及包含这些化合物的制药组合物以及使用它们治疗血栓栓塞和/或炎症性疾病的方法。